Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Thyrocare Technologies Ltd ( (IN:THYROCARE) ) has issued an announcement.
Thyrocare Technologies Limited has announced that, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, the company has confirmed that all of its shares are held in dematerialized form, with no requests for rematerialization received during the quarter ending March 31, 2025. This announcement signifies the company’s adherence to regulatory requirements, ensuring transparency and efficiency in its shareholding structure, which is crucial for maintaining investor confidence and operational integrity.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Limited operates in the healthcare industry, primarily focusing on diagnostic and preventive healthcare services. The company is known for its extensive range of medical testing and diagnostic services, catering to a wide market segment that includes both individual consumers and healthcare providers.
YTD Price Performance: -26.52%
Average Trading Volume: 4,375
Current Market Cap: 36.81B INR
See more data about THYROCARE stock on TipRanks’ Stock Analysis page.